Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Organisation › Details

Orchard Therapeutics Ltd.

Orchard Therapeutics is a privately held, clinical-stage biotechnology company based in London, UK and Foster City, California. Orchard is developing gene therapies for patients with severe and life-threatening inherited diseases working in partnership with some of the world's leading centres in gene therapy, including University College London, Great Ormond Street Hospital for Children NHS Foundation Trust, the University of Manchester and Central Manchester University Hospitals NHS Foundation Trust, the University of California Los Angeles and Boston Children’s Hospital. In 2016 the company was named a Fierce 15 Company by Fierce Biotech. *

 

Period Start 2015-09-02 established
  Group Orchard Therapeutics (Group)
Products Industry gene therapy
  Industry 2 DRUGS, ORPHAN
Persons Person Rothera, Mark (Orchard Therapeutics 201708– CEO before PTC Therapeutics + Aegerion + Shire Human Genetic Therapies)
  Person 2 Thomas, Frank (Orchard Therapeutics 201801– CFO + CBO before AMAG Pharmaceuticals + Molecular Biometrics Inc)
     
Region Region London, Greater London
  Country United Kingdom (GB)
  Street 108 Cannon Street
  City EC4N 6EU London
  Tel +44-203-384-6700
    Address record changed: 2019-01-08
     
Basic data Employees n. a.
     
    * Document for �About Section�: Orchard Therapeutics Ltd.. (8/10/17). "Press Release: Orchard Therapeutics Appoints Mark Rothera as CEO". London.
     
   
Record changed: 2019-03-31

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Orchard Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top